TrialPath
Recruiting

PALLAS Laser for Skin Diseases

NCT07250997 · Szeged University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Study of the Effectiveness of the PALLAS Laser in the Treatment of Skin Diseases That Respond Well to UV Light
About this study
This clinical study is a prospective testing and assessment of a CE marked PALLAS laser device within its intended use, carried out in one centre. PALLAS is a solid-state ultraviolet laser system with 311 nm emission wavelength for tissue incision, destruction and removal. The laser is intended for use on different parts of the skin, typically the face, hands, arms, feet or legs. Pallas eliminates the shortcomings of currently used excimer lasers, such as the instability of the emitted energy and the expensive maintenance costs. The energy emitted by the laser is stable over a long period of time, maximising the effectiveness of the treatments and minimising the potential side effects of skin burns. EUDAMED registration LASEROPTEK sheet with SRN number: https://ec.europa.eu/tools/eudamed/#/screen/search-eo/61c45e80-9297-4dcd-8940-8f7ccad5ef22 Actor ID/SRN: KR-MF-000018426
Eligibility criteria
Inclusion Criteria: 1. The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to participate, 2. a skin condition that is expected to respond well to targeted UVB treatment, 3. a signed consent form. Exclusion Criteria: 1. Patient under 18 years of age, 2. pregnancy 3. epilepsy, 4. fever, infectious diseases, 5. the patient is within one month or currently enrolled in another clinical trial.
Study design
Enrollment target: 50 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2025-12-10
Estimated completion: 2026-12-31
Last updated: 2026-02-06
Interventions
Device: UVB laser treatment
Primary outcomes
  • • Primary Endpoint: visible improvement of the treated skin disease. (maximum 3 months)
Sponsor
Szeged University · other
Contacts & investigators
ContactLajos Kemény, professor, MD, DSc, MHAS · contact · kemeny.lajos@med.u-szeged.hu · +36305152884
All locations (1)
University of Szeged, Albert Szent-Györgyi Clinical Centre, Department of Dermatology and AllergologyRecruiting
Szeged, Csongrád-Csanád Vármegye, Hungary
PALLAS Laser for Skin Diseases · TrialPath